The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $766,254 purchase order to ANP Technologies Inc. to develop Lightweight Field Instruments in support of the Coronavirus COVID-19 national interest. The firm fixed price contract will be performed in Newark, Delaware through May 31, 2020. No subcontractors or set aside designations were identified. The award provides urgently needed equipment to the Chemical and Biological Defense program's...
This is a $600,250.78 firm fixed price definitive contract awarded by the U.S. Army Contracting Command - Warren (ACC Warren) to ANP Technologies Inc., a minority-owned, for-profit business focused on nanobiotechnology and diagnostic products. The contract is for the delivery of Handheld Assay Systems (HHAS) with a completion date of February 12, 2022. This award does not have a set-aside designation. ANP Technologies has provided COVID-19 test kits and supplies, as well as other biological...
Princeton Biomeditech Corp was awarded a definitive, firm fixed price contract valued at $10,062,372.12 by the Department of Health and Human Services' National Institutes of Health National Heart, Lung and Blood Institute. The contract is for RADX TECH II PROJECTS 13356 & 13464, which involves developing and delivering a rapid, point-of-care multiplex assay and reader to simultaneously detect COVID-19 and influenza A & B antigens. Work will be performed in Monmouth Junction, New...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a firm fixed price purchase order contract to Ascella Biosystems Inc., a for-profit manufacturer, on January 13, 2021. The $250,000.00 contract is for RADX-TECH - SUPPORT SERVICES NEEDED FOR WORK PACKAGE 1 and is associated with the Coronavirus COVID-19 national interest action. The contract does not have a set-aside designation and is scheduled for completion on January...
This definitive contract from the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awards Nanomix, Inc. $569,647 to develop rapid antigen and antibody tests for COVID-19. The contract aligns with Special Instructions 019 under the agency's Easy Broad Agency Announcement BAA-20-100-SOL-0002, which seeks host-directed therapeutic candidates to improve long-term outcomes from lung injury. As the prime contractor, Nanomix will perform work in...
This is a delivery order contract awarded by the Department of the Army Materiel Command TACOM Life Cycle Management Command to ANP Technologies Inc. to provide hand-held assays during the ordering period of September 2, 2017 through September 1, 2018. The $1,411,984.20 firm fixed price contract has no set-aside designation and was awarded on December 12, 2017, with a completion date of June 1, 2018. ANP Technologies is a minority-owned, for-profit, Asian-Pacific American manufacturer...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $167,000 firm fixed price delivery order contract to ANP Technologies Inc. of Newark, Delaware. The contract is for the delivery of optimized life-saving force kits in support of the Coronavirus COVID-19 national interest and will be performed in Newark through January 2021. No subcontractors or set aside designations were indicated. The funding agency, part of the Army chemical and...
This is a delivery order (W56HZV14D0120|0002) awarded by the U.S. Army TACOM Life Cycle Management Command to ANP Technologies Inc., a minority-owned, Asian-Pacific American-owned manufacturer of goods, for the delivery of 9,300 hand-held assays. The contract is a firm fixed-price delivery order with a ceiling value of $590,922.00 and a completion date of November 25, 2015. ANP Technologies has an Indefinite Delivery Contract from the Army's Chemical and Biological Defense program with a...
This contract was awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Luminostics Inc., a for-profit medical technology company. The $39,067,500.00 Firm Fixed Price contract is for the RADX-TECH program to develop and deliver a smartphone-based point-of-care test for rapid SARS-CoV-2 antigen detection from nasal swabs. This contract was not set aside for any particular business type. Luminostics has received prior federal contract and grant awards related to...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB), a civilian agency, awarded a $3,750,864 firm-fixed-price contract to Avantgen Inc., a San Diego-based biotechnology company, to develop a highly sensitive rapid test kit for SARS-CoV-2 that does not require a reader. This contract is part of the Rapid Acceleration of Diagnostics (RADx) program and has a completion date of September 29, 2023. The contract was not set aside for any specific business type. Avantgen has...